Susquehanna International Group
SCPH

Susquehanna International Group’s scPharmaceuticals SCPH Stock Holding History

Susquehanna International Group’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,900
Closed -$243K – 13472
2025
Q3 		$243K Sell
42,900
-98,500
-70% -$504K ﹤0.01% 10577
2025
Q2 		$539K Buy
141,400
+59,400
+72% +$184K ﹤0.01% 9008
2025
Q1 		$216K Sell
82,000
-18,400
-18% -$59.9K ﹤0.01% 10790
2024
Q4 		$355K Buy
100,400
+10,800
+12% +$41.4K ﹤0.01% 9455
2024
Q3 		$409K Buy
89,600
+77,700
+653% +$376K ﹤0.01% 8955
2024
Q2 		$51.8K Sell
11,900
-3,200
-21% -$14.1K ﹤0.01% 11400
2024
Q1 		$75.8K Sell
15,100
-500
-3% -$2.8K ﹤0.01% 11361
2023
Q4 		$97.8K Sell
15,600
-37,300
-71% -$214K ﹤0.01% 11351
2023
Q3 		$377K Buy
52,900
+36,300
+219% +$286K ﹤0.01% 8871
2023
Q2 		$169K Sell
16,600
-5,100
-24% -$53.2K ﹤0.01% 10450
2023
Q1 		$197K Buy
21,700
+6,700
+45% +$49.1K ﹤0.01% 10613
2022
Q4 		$108K Buy
+15,000
New +$91.6K ﹤0.01% 10904

Susquehanna International Group's SCPH Position: Q3 2025 in Review

Susquehanna International Group sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 138,460 shares — an estimated $709K sold.

Susquehanna International Group first reported a position in SCPH in Q4 2018 and held it in 16 quarters. The position peaked at $2.06M in Q1 2023. 109 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

  • Susquehanna International Group reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 138,460 scPharmaceuticals shares in Q3 2025, an estimated $709K.
  • Susquehanna International Group first reported a position in scPharmaceuticals in Q4 2018 and held it in 16 quarters.
  • Susquehanna International Group's scPharmaceuticals position peaked at $2.06M in Q1 2023.
  • 109 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.